Skip to main content
رجوع
Watch Compare

Kyverna Therapeutics, Inc.

جودة البيانات: 83%
KYTX
Nasdaq Manufacturing Chemicals
KWD 8.95
▼ KWD 0.63 (-6.58%)
القيمة السوقية: 567.07 M
السعر
KWD 9.38
القيمة السوقية
567.07 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Negative free cash flow of -153.72 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-95.92%
أقل من متوسط القطاع (-53.41%)
ROIC-78.92%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio5.16
Interest Coverage-347.29

التقييم

PE (TTM)
-3.52
أقل من متوسط القطاع (-1.48)
P/B Ratio3.73
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -3.5 -1.5
P/B 3.7 1.6
ROE % -95.9 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

BRUSX BRUSX
1.16% weight
BRSIX BRSIX
0.11% weight
GSCYX GSCYX
0.00% weight
GSCZX GSCZX
0.00% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -161.31 M
ROE -95.92% ROA -77.99%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -153.72 M
ROIC -78.92% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.16
Interest Coverage -347.29 Asset Turnover N/A
Working Capital 141.05 M Tangible Book Value 151.95 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.52 Forward P/E N/A
P/B Ratio 3.73 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -27.11%
Market Cap 567.07 M Enterprise Value 532.91 M
Per Share
EPS (Diluted TTM) -3.64 Revenue / Share N/A
FCF / Share -2.54 OCF / Share -2.54
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 95.29%
SBC-Adj. FCF -163.37 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -161.31 M -127.48 M
EPS (Diluted) -3.64 -3.33
Gross Profit — —
Operating Income -169.83 M -142.60 M
EBITDA — —
R&D Expenses 133.72 M 112.47 M
SG&A Expenses — —
D&A 1.80 M 2.13 M
Interest Expense 489,000.0 142,000.0
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 293.83 M 304.65 M
Total Liabilities 61.55 M 38.06 M
Shareholders' Equity 232.28 M 266.59 M
Total Debt — —
Cash & Equivalents 124.09 M 96.62 M
Current Assets 282.95 M 290.60 M
Current Liabilities 36.49 M 33.76 M